Chemoinformaics analysis of 2,5-Dimethoxy-p-cymene
Molecular Weight | 194.274 | nRot | 3 |
Heavy Atom Molecular Weight | 176.13 | nRig | 6 |
Exact Molecular Weight | 194.131 | nRing | 1 |
Solubility: LogS | -4.197 | nHRing | 0 |
Solubility: LogP | 3.778 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 33.6463 |
nHD | 0 | BPOL | 21.5297 |
QED | 0.736 |
Synth | 1.788 |
Natural Product Likeliness | 0.058 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.08 |
Pgp-sub | 0.407 |
HIA | 0.006 |
CACO-2 | -4.595 |
MDCK | 0.0000214 |
BBB | 0.733 |
PPB | 0.959095 |
VDSS | 1.992 |
FU | 0.0357985 |
CYP1A2-inh | 0.897 |
CYP1A2-sub | 0.965 |
CYP2c19-inh | 0.636 |
CYP2c19-sub | 0.935 |
CYP2c9-inh | 0.249 |
CYP2c9-sub | 0.838 |
CYP2d6-inh | 0.171 |
CYP2d6-sub | 0.923 |
CYP3a4-inh | 0.215 |
CYP3a4-sub | 0.667 |
CL | 9.192 |
T12 | 0.408 |
hERG | 0.017 |
Ames | 0.074 |
ROA | 0.082 |
SkinSen | 0.131 |
Carcinogencity | 0.347 |
EI | 0.96 |
Respiratory | 0.047 |
NR-Aromatase | 0.012 |
Antiviral | No |
Prediction | 0.633303 |